| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4321733 | Neuron | 2011 | 4 Pages |
Abstract
The potential use of drugs to enhance cognition, emotion, and executive function has engendered controversy despite the fact that few such agents exist today. Here, I provide a context for discussions based on medical, regulatory, and ethical concerns that have been raised by the possibility that enhancers will emerge from current efforts to discover drugs for neuropsychiatric disorders.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Steven E. Hyman,